Geninus Inc. (389030) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Geninus Inc. (389030:KRX), powered by AI.

Current Price
₩6,110
P/E Ratio
-16.6
Market Cap
203.8B
Sector
Healthcare
What is the Geninus Inc. stock price forecast?

Geninus Inc. is currently trading at ₩6,110. View real-time AI analysis on Alpha Lenz.

What is Geninus Inc. insider trading activity?

View the latest insider trading data for Geninus Inc. on Alpha Lenz.

What is Geninus Inc.'s P/E ratio?

Geninus Inc.'s P/E ratio is -16.6.

Geninus Inc.

KRX · 389030
₩6,110
Ask about Geninus Inc.'s future dividend policy...
Alpha Chat Insight

Geninus Inc. trades at a P/E of -16.6 (undervalued) with modest ROE of -43.3%.

Ask for details

Company Overview

Geninus Inc. operates as a biotechnology firm focused on the development and commercialization of genomic insights and solutions. The company's primary function is to harness advanced genetic data to inform personalized medicine strategies and enhance patient outcomes. Geninus Inc. stands as a pivotal player in the healthcare and life sciences sector, facilitating precision medicine through its cutting-edge technology platforms and services. By offering diagnostic tools, sequencing solutions, and data analytics, Geninus Inc. empowers healthcare providers, researchers, and patients with actionable genomic information. The firm plays a critical role in the evolution of targeted therapies and personalized treatments, primarily impacting healthcare systems and pharmaceutical research. As genomic technology gains prominence, Geninus Inc.'s contributions are central to driving innovations in disease prediction, prevention, and treatment, highlighting its market significance and influence in shaping the future of medical and therapeutic landscapes.

CEO박웅양
SectorHealthcare
IndustryBiotechnology
Employees74

Company Statistics

FY 2024

Profile

₩203,779,772,950Market Cap
₩6,455,439,510Revenue
33.35MShares Out
74Employees

Margins

1.26%Gross
-144.95%EBITDA
-189.91%Operating
-190.12%Pre-Tax
-190.12%Net

Valuation

-16.59P/E
9.16P/B
31.55EV/Sales
-21.86EV/EBITDA
-14.76P/FCF

Growth (CAGR)

-7.42%Rev 3Yr
36.23%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-33.34%ROA
-43.27%ROE
-32.92%ROIC

Financial Health

₩5,243,974,700Cash & Cash Equivalents
₩5,607,930,070Net Debt
48.80%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Geninus Inc. (ticker: 389030) is a company listed on KRX in the Healthcare sector (Biotechnology). It has approximately 74 employees. Market cap is $203.8B.

The current price is ₩6,110 with a P/E ratio of -16.59x and P/B of 9.16x.

ROE is -43.27% and operating margin is -189.91%. Annual revenue is $6.5B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Geninus Inc. (Healthcare) Stock Forecast & Analysis ₩6,110 | Alpha Lenz